Ozmosi | Perifosine Drug Profile
Drug Search Results
Using advanced filters...
Advanced Search [+]

Perifosine

Alternative Names: perifosine
Clinical Status: Inactive
Latest Update: 2024-03-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: Akt Inhibitor, PI3K Modulator

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: AEterna Zentaris
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Phase 3: Multiple Myeloma|Colorectal Cancer

Phase 2: Ovarian Cancer|Prostate Cancer|Adenocarcinoma|Cervical Cancer|Non-Small-Cell Lung Cancer|Waldenstrom Macroglobulinemia|Glioblastoma|Renal Cell Carcinoma|Colorectal Cancer|Pancreatic Cancer|Gliosarcoma|Sarcoma|Oligodendroglioma|Multiple Myeloma|Breast Cancer|Astrocytoma|Leukemia|Kidney Cancer|Alveolar Soft Part Sarcoma|Gastrointestinal Stromal Tumors|Lymphocytic Chronic B-Cell Leukemia|Chronic Lymphoid Leukemia|Lymphoma, B-Cell|Brain Cancer|Chondrosarcoma|Endometrial Cancer|Lymphoma|Melanoma|Glioma|Head and Neck Cancer

Phase 1: Renal Cell Carcinoma|Ovarian Cancer|Oncology Solid Tumor Unspecified|Myelogenous, Chronic, BCR-ABL Positive Leukemia|Prostate Cancer|Acute Myelomonocytic Leukemia|Myeloproliferative Disorders|Kidney Cancer|Neuroblastoma|Diarrhea|Acute Promyelocytic Leukemia|Chronic Myelomonocytic Leukemia|Precursor Cell Lymphoblastic Leukemia-Lymphoma|Acute Myeloid Leukemia|Preleukemia|Myelodysplastic-Myeloproliferative Diseases|Liver Cancer|Myelodysplastic Syndrome|Chronic Myeloid Leukemia|Angina, Unstable|Heart Failure, Acute|Chronic Lymphoid Leukemia|Acute Megakaryoblastic Leukemia|Acute Erythroblastic Leukemia|Precursor T-Cell Lymphoblastic Leukemia-Lymphoma|Acute Monocytic Leukemia|Adult T-Cell Leukemia-Lymphoma|Acute Lymphoid Leukemia|Myeloid, Accelerated Leukemia|Blast Crisis|Brain Cancer|Oligodendroglioma|Astrocytoma|Hypokalemia|Hepatitis C, Chronic|Heart Failure, Chronic|Hypertrophy, Left Ventricular|Angina, Stable|Myocardial Infarction|Glioblastoma|Angina Pectoris|Lymphoma|Hepatitis B, Chronic|Pregnancy Outcomes|Neuromyelitis Optica|Surgical Wound Infection|HIV Infections|Contraception|Torsades de Pointes|Colorectal Cancer|Multiple Myeloma

Trial ID

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

NCT00847366

Perifosine 534

N/A

Completed

Breast Cancer|Sarcoma|Non-Small-Cell Lung Cancer|Multiple Myeloma

2012-12-01

2025-02-07

Primary Endpoints|Treatments

NCT02238496

AAAM3801

P1

Completed

Glioblastoma|Astrocytoma|Oligodendroglioma|Brain Cancer

2017-10-27

88%

2023-05-26

Primary Endpoints|Treatments

NCT00776867

NCT00776867

P1

Completed

Oncology Solid Tumor Unspecified

2017-07-01

2019-03-18

NCT01049841

NCT01049841

P1

Completed

Oncology Solid Tumor Unspecified

2017-03-01

2025-08-27

Primary Endpoints|Treatments

JapicCTI-132130

JapicCTI-132130

P1

Completed

Neuroblastoma

2015-11-01

NCT01224730

Protocol 147

P1

Completed

Myocardial Infarction|Angina, Stable|Angina, Unstable|Heart Failure, Acute|Hepatitis B, Chronic|Torsades de Pointes|HIV Infections|Hypertrophy, Left Ventricular|Pregnancy Outcomes|Contraception|Heart Failure, Chronic|Neuromyelitis Optica|Hypokalemia|Angina Pectoris|Hepatitis C, Chronic|Surgical Wound Infection

2013-11-04

2019-03-19

Treatments

JapicCTI-121748

JapicCTI-121748

P1

Terminated

Multiple Myeloma

2012-12-31

NCT00415064

Perifosine 127

P1

Completed

Multiple Myeloma

2012-07-01

2025-08-27

Primary Endpoints|Treatments

NCT00301938

NCI-2009-00149

P1

Completed

Myelodysplastic-Myeloproliferative Diseases|Chronic Myelomonocytic Leukemia|Precursor Cell Lymphoblastic Leukemia-Lymphoma|Myelodysplastic Syndrome|Adult T-Cell Leukemia-Lymphoma|Acute Myeloid Leukemia|Chronic Myeloid Leukemia|Acute Megakaryoblastic Leukemia|Acute Promyelocytic Leukemia|Preleukemia|Chronic Lymphoid Leukemia|Acute Monocytic Leukemia|Blast Crisis|Myeloid, Accelerated Leukemia|Acute Lymphoid Leukemia|Myelogenous, Chronic, BCR-ABL Positive Leukemia|Precursor T-Cell Lymphoblastic Leukemia-Lymphoma|Myeloproliferative Disorders|Acute Erythroblastic Leukemia|Acute Myelomonocytic Leukemia

2012-05-01

2019-03-21

NCT00431054

Pharmacodynamic Trial

P1

Completed

Ovarian Cancer

2012-05-01

2019-03-21

Treatments

NCT00398814

Perifosine 124

P1

Completed

Renal Cell Carcinoma|Kidney Cancer

2011-09-01

2019-03-21

Treatments

NCT01048580

Perifosine 141

P1

Completed

Colorectal Cancer

2011-05-01

2019-03-19

Treatments

NCT00590954

NCT00590954

P2

Completed

Glioma|Brain Cancer

2019-11-11

2025-08-27

Primary Endpoints|Treatments

NCT01051557

NCI-2011-01409

P2

Completed

Astrocytoma|Glioblastoma|Oligodendroglioma|Gliosarcoma

2018-11-16

2021-07-20

JapicCTI-132287

JapicCTI-132287

P2

Completed

Ovarian Cancer|Cervical Cancer

2015-11-30

JapicCTI-111712

JapicCTI-111712

P2

Terminated

Colorectal Cancer

2013-07-31

NCT00873457

Pro00015060

P2

Completed

Lymphocytic Chronic B-Cell Leukemia|Lymphoma, B-Cell|Chronic Lymphoid Leukemia

2011-10-01

2019-03-18

Treatments

NCT00398710

Perifosine 221

P2

Completed

Waldenstrom Macroglobulinemia

2011-08-01

2019-03-21

Treatments

NCT00389077

Perifosine 207

P2

Completed

Lymphoma

2011-07-01

2019-03-21

Treatments

NCT00498966

Perifosine 231

P2

Completed

Kidney Cancer

2011-07-01

2019-03-21

Treatments

NCT00401388

Perifosine 214

P2

Completed

Chondrosarcoma|Alveolar Soft Part Sarcoma

2011-01-01

2019-03-22

Treatments

NCT00398879

Perifosine 211

P2

Completed

Colorectal Cancer

2010-12-01

2019-03-21

Treatments

2010-018893-19

2010-018893-19

P3

Terminated

Multiple Myeloma

2013-03-11

2022-03-13

Treatments

NCT01002248

Perifosine 339

P3

Terminated

Multiple Myeloma

2013-03-01

2025-08-27

Primary Endpoints|Treatments

NCT01097018

X-PECT

P3

Completed

Colorectal Cancer

2012-04-01

2019-03-19

Treatments